𝔖 Bobbio Scriptorium

✦ LIBER ✦

Sequential Intravesical Chemoimmunotherapy with Mitomycin C and Bacillus Calmette-Guérin and with Bacillus Calmette-Guérin Alone in Patients with Carcinoma in Situ of the Urinary Bladder: Results of an EORTC Genito-Urinary Group Randomized Phase 2 Trial (30993)

✍ Scribed by Willem Oosterlinck; Ziya Kirkali; Richard Sylvester; Fernando Calais da Silva; Christer Busch; Ferran Algaba; Sandra Collette; Aldo Bono

Book ID: 113612122
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 328 KB
Volume: 59
Category: Article
ISSN: 0302-2838
DOI: 10.1016/j.eururo.2010.11.038

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Re: Willem Oosterlinck, Ziya Kirkali, Ri

Re: Willem Oosterlinck, Ziya Kirkali, Richard Sylvester, et al. Sequential Intravesical Chemoimmunotherapy with Mitomycin C and Bacillus Calmette-Guérin and with Bacillus Calmette-Guérin Alone in Patients with Carcinoma in Situ of the Urinary Bladder: Results of an EORTC Genito-Urinary Group Randomized Phase 2 Trial (30993). Eur Urol 2011;59:438–46

✍ Wei Ling Ooi; Martin Stockler; Dickon Hayne 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Long-Term Efficacy Results of EORTC Geni

Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guérin, and Bacillus Calmette-Guérin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder

✍ Richard J. Sylvester; Maurizio A. Brausi; Wim J. Kirkels; Wolfgang Hoeltl; Ferna 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 408 KB

Re: Long-Term Efficacy Results of EORTC

Re: Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guérin, and Bacillus Calmette-Guérin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder

✍ Donald L. Lamm 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 70 KB

Re: Long-Term Efficacy Results of EORTC

Re: Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guérin, and Bacillus Calmette-Guérin Plus Isoniazid in Patients With Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder

✍ Wood, David P. 📂 Article 📅 2011 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 52 KB

A phase II clinical trial of oral bropir

A phase II clinical trial of oral bropirimine in combination with intravesical bacillus Calmette-Guérin for carcinoma in situ of the bladder: A Southwest Oncology Group Study

✍ Michael F. Sarosdy; Catherine M. Tangen; Geoffrey R. Weiss; Blake R. Nestok; Mit 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 142 KB

Re: Richard J. Sylvester, Maurizio A. Br

Re: Richard J. Sylvester, Maurizio A. Brausi, Wim J. Kirkels, et al. Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guérin, and Bacillus Calmette-Guérin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder. Eur Urol 2010;57:766–73

✍ Tommaso Cai; Lorenzo Giuseppe Luciani; Gianni Malossini 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 60 KB